The company have significantly boosted this course of a novel treatment for amyloid heart disease, utilizing Attruby. Preliminary clinical information reveals potential benefits for those affected by the serious condition. This emphasis highlights BridgeBio's focus to treating unmet medical needs in a heart field. Attruby: BridgeBio's Novel Approa